Diagnosis dan Tata Laksana Nefritis Lupus

Penulis

  • Maia Thalia Giani Instalasi Gawat Darurat, Rumah Sakit Umum Daerah Kabupaten Karanganyar, Karanganyar,Jawa Tengah, Indonesia
  • Muhammad Raditia Septian Instalasi Gawat Darurat, Rumah Sakit PKU Muhammadiyah Surakarta, Surakarta, Jawa Tengah, Indonesia

DOI:

https://doi.org/10.55175/cdk.v49i12.324

Kata Kunci:

Diagnosis, lupus eritematosus sistemik, nefritis lupus, tatalaksana

Abstrak

Nefritis lupus merupakan salah satu manifestasi lupus eritematosus sistemik dengan morbiditas dan mortalitas tinggi. Penegakan diagnosis menjadi salah satu tantangan dalam praktik kedokteran sehari-hari. Tata laksana dini dapat memperbaiki kelangsungan serta kualitas hidup pasien.   Lupus nephritis is one of manifestations of systemic lupus erythematosus with high morbidity and mortality. Diagnosis of lupus nephritis may be challenging in daily medical practice. Early initiation of treatment can improve patient survival and quality of life.

 

Unduhan

Data unduhan belum tersedia.

Referensi

McClure M, Jones R. Update on lupus nephritis for GPs. Lupus 2018;27(1_suppl):11–4.

Morales E, Galindo M, Trujillo H, Praga M. Update on lupus nephritis: Looking for a new vision. Nephron. 2021;145(1):1–13.

Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: A systematic review of epidemiological studies. Rheumatol (United Kingdom). 2017;56(11):1945–61.

Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: An update. Curr Opin Rheumatol. 2018;30(2):144–50.

Drenkard C, Lim SS. Update on lupus epidemiology: Advancing health disparities research through the study of minority populations. Curr Opin Rheumatol. 2019;31(6):689–96.

Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: Results from an international inception cohort study. Rheumatology 2016;55(2):252–62.

Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004. Arthritis Rheum. 2013;65(3):753–63.

Anders HJ, Saxena R, Zhao M hui, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Prim [Internet]. 2020;6(1). Available from: http://dx.doi.org/10.1038/ s41572-019-0141-9

Kementerian Kesehatan RI. Infodatin Lupus di Indonesia. Pusat Data dan Informasi Kementerian Kesehatan RI; 2017. p. 8.

Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol [Internet]. 2015;11(6):329–41. Available from: https://www.nature.com/articles/nrneph.2015.33. http://dx.doi.org/10.1038/nrneph.2015.33

Iwamoto T, Niewold TB. Genetics of human lupus nephritis. Clin Immunol. 2017;185:32–9.

Obrișcă B, Sorohan B, Tuță L, Ismail G. Advances in lupus nephritis pathogenesis: From bench to bedside. Int J Mol Sci. 2021;22(7):3766.

Schwartz N, Goilav B, Putterman C. The pathogenesis, diagnosis and treatment of lupus nephritis. Curr Opin Rheumatol. 2014;26(5):502–9.

Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: Core curriculum 2020. Am J Kidney Dis [Internet]. 2020;76(2):265–81. Available from: https:// www.ajkd.org/article/S0272-6386(19)31170-9/fulltext. https://doi.org/10.1053/j.ajkd.2019.10.017

Waage, et al. Eular/Acr 2019. Physiol Behav. 2017;176(1):139–48.

Perhimpunan Reumatologi Indonesia [Internet]. 2019. Available from: https://reumatologi.or.id/wp-content/uploads/2020/10/Diagnosis_dan_pengelolaan_SLE.pdf

Dooley MA. Clinical and epidemiologic features of lupus nephritis. Wallace DJ, Hahn BH, Dubois’ Lupus erythematosus and related syndromes. Philadelphia. PA: Elsevier Saunders; 2013.

Anders HJ, Rovin B. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Kidney Int [Internet]. 2016;90(3):493–501. Available from: https://pubmed.ncbi.nlm.nih.gov/27378475/. doi: 10.1016/j.kint.2016.05.017.

Stokes MB, D’Agati VD. Classification of lupus nephritis; Time for a change? Adv Chronic Kidney Dis. 2019;26(5):323–9.

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JHM, et al. Joint European League Against Rheumatism and European Renal Association– European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–82.

Weening JJ, D’agati VD, Schwartz MM, Seshan S V, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–30.

Mok CC. Understanding lupus nephritis: Diagnosis, management, and treatment options. Int J Womens Health. 2012;4:213.

Dall’Era M. Treatment of lupus nephritis: Current paradigms and emerging strategies. Curr Opin Rheumatol. 2017;29(3):241–7.

Alvarado AS, Malvar A, Lococo B, Alberton V, Toniolo F, Nagaraja HN, et al. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients. Lupus 2014;23(8):840–7.

Costenbader KH, Desai A, Alarcón GS, Hiraki LT, Shaykevich T, Brookhart MA, et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011;63(6):1681–8.

Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, et al. Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2016;75(11):1909–16.

Dooley MA, Houssiau F, Aranow C, D’Cruz DP, Askanase A, Roth DA, et al. Effect of belimumab treatment on renal outcomes: Results from the phase 3 belimumab clinical trials in patients with SLE. Lupus 2013;22(1):63–72.

Furie R, Nicholls K, Cheng T, Houssiau F, Burgos-Vargas R, Chen S, et al. Efficacy and safety of abatacept in lupus nephritis: A twelve-month, randomized, double-blind study. Arthritis Rheumatol. 2014;66(2):379–89.

Zhen Y, Lee IJ, Finkelman FD, Shao WH. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis. J Autoimmun. 2018;93:37–44.

Gołębiewska J, Dębska–Ślizień A, Bułło–Piontecka B, Rutkowski B. Outcomes in renal transplant recipients with lupus nephritis—A single–center experience and review of the literature. Transplantation proceedings. Elsevier; 2016. p. 1489–93.

Parodis I, Tamirou F, Houssiau FA. Prediction of prognosis and renal outcome in lupus nephritis. Lupus Sci Med. 2020;7(1):1–6.

Rodríguez-Almaraz E, Gutiérrez-Solís E, Rabadán E, Rodríguez P, Carmona L, Morales E, et al. Something new about prognostic factors for lupus nephritis? A systematic review. Lupus 2021;30(14):2256–67.

Diterbitkan

2022-12-01

Cara Mengutip

Giani, M. T., & Septian, M. R. (2022). Diagnosis dan Tata Laksana Nefritis Lupus. Cermin Dunia Kedokteran, 49(12), 671–676. https://doi.org/10.55175/cdk.v49i12.324

Terbitan

Bagian

Articles